Search details
1.
The current state of molecular testing in the treatment of patients with solid tumors, 2019.
CA Cancer J Clin
; 69(4): 305-343, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31116423
2.
Cell death: a new Par-4 the TRAIL.
Cell
; 138(2): 220-2, 2009 Jul 23.
Article
in English
| MEDLINE | ID: mdl-19632170
3.
Therapeutic targeting of TRAIL death receptors.
Biochem Soc Trans
; 51(1): 57-70, 2023 02 27.
Article
in English
| MEDLINE | ID: mdl-36629496
4.
Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer.
Int J Mol Sci
; 24(4)2023 Feb 20.
Article
in English
| MEDLINE | ID: mdl-36835649
5.
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer.
Int J Mol Sci
; 24(13)2023 Jun 29.
Article
in English
| MEDLINE | ID: mdl-37446056
6.
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents.
Medicina (Kaunas)
; 58(12)2022 Dec 10.
Article
in English
| MEDLINE | ID: mdl-36557020
7.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Article
in English
| MEDLINE | ID: mdl-29466156
8.
Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents.
Int J Mol Sci
; 22(21)2021 Oct 31.
Article
in English
| MEDLINE | ID: mdl-34769259
9.
Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer.
Oncologist
; 24(11): 1416-1419, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31444293
10.
Acoustic separation of circulating tumor cells.
Proc Natl Acad Sci U S A
; 112(16): 4970-5, 2015 Apr 21.
Article
in English
| MEDLINE | ID: mdl-25848039
11.
The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death.
J Biol Chem
; 291(11): 5960-5970, 2016 Mar 11.
Article
in English
| MEDLINE | ID: mdl-26757822
12.
GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress.
Mol Cell
; 36(3): 379-92, 2009 Nov 13.
Article
in English
| MEDLINE | ID: mdl-19917247
13.
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway.
Mol Cancer
; 14: 99, 2015 May 01.
Article
in English
| MEDLINE | ID: mdl-25927855
14.
TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess.
J Hepatol
; 62(5): 1156-63, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25445398
15.
Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.
Cancer Cell
; 12(1): 66-80, 2007 Jul.
Article
in English
| MEDLINE | ID: mdl-17613437
16.
Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells.
Clin Chem
; 60(2): 323-33, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24132944
17.
Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure.
Oncotarget
; 15: 275-284, 2024 May 03.
Article
in English
| MEDLINE | ID: mdl-38709242
18.
Dopamine pre-treatment impairs the anti-cancer effect of integrated stress response- and TRAIL pathway-inducing ONC201, ONC206 and ONC212 imipridones in pancreatic, colorectal cancer but not DMG cells.
Am J Cancer Res
; 14(5): 2453-2464, 2024.
Article
in English
| MEDLINE | ID: mdl-38859853
19.
miR-6883 downregulates HIF1α in colorectal and breast cancer cells.
MicroPubl Biol
; 20242024.
Article
in English
| MEDLINE | ID: mdl-38344066
20.
Predictive and prognostic biomarkers in urological tumours.
Pathology
; 56(2): 228-238, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38199927